Cargando…

BK Channel in the Physiology and in the Cancer of Pancreatic Duct: Impact and Reliability of BK Openers

BK (KCa 1.1, Slo-1) is a K(+) channel characterized by an allosteric regulation of the gating mechanism by Ca(2+) binding and voltage, and a high unitary conductance. The channel is expressed in many different tissues, where it is involved in the regulation or the fine-tuning of many physiological p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuccolini, Paolo, Gavazzo, Paola, Pusch, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171006/
https://www.ncbi.nlm.nih.gov/pubmed/35685628
http://dx.doi.org/10.3389/fphar.2022.906608
_version_ 1784721563997700096
author Zuccolini, Paolo
Gavazzo, Paola
Pusch, Michael
author_facet Zuccolini, Paolo
Gavazzo, Paola
Pusch, Michael
author_sort Zuccolini, Paolo
collection PubMed
description BK (KCa 1.1, Slo-1) is a K(+) channel characterized by an allosteric regulation of the gating mechanism by Ca(2+) binding and voltage, and a high unitary conductance. The channel is expressed in many different tissues, where it is involved in the regulation or the fine-tuning of many physiological processes. Among other organs, BK is expressed in the pancreatic duct, a part of the gland important for the correct ionic composition of the pancreatic juice. Unfortunately, the pancreatic duct is also the site where one of the deadliest cancer types, the pancreatic duct adenocarcinoma (PDAC), develops. In the past years, it has been reported that continuous exposure of cancer cells to BK openers can have a significant impact on cell viability as well as on the ability to proliferate and migrate. Here, we first summarize the main BK channel properties and its roles in pancreatic duct physiology. Then we focus on the potential role of BK as a pharmacological target in PDAC. Moreover, we discuss how results obtained when employing BK activators on cancer cells can, in some cases, be misleading.
format Online
Article
Text
id pubmed-9171006
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-91710062022-06-08 BK Channel in the Physiology and in the Cancer of Pancreatic Duct: Impact and Reliability of BK Openers Zuccolini, Paolo Gavazzo, Paola Pusch, Michael Front Pharmacol Pharmacology BK (KCa 1.1, Slo-1) is a K(+) channel characterized by an allosteric regulation of the gating mechanism by Ca(2+) binding and voltage, and a high unitary conductance. The channel is expressed in many different tissues, where it is involved in the regulation or the fine-tuning of many physiological processes. Among other organs, BK is expressed in the pancreatic duct, a part of the gland important for the correct ionic composition of the pancreatic juice. Unfortunately, the pancreatic duct is also the site where one of the deadliest cancer types, the pancreatic duct adenocarcinoma (PDAC), develops. In the past years, it has been reported that continuous exposure of cancer cells to BK openers can have a significant impact on cell viability as well as on the ability to proliferate and migrate. Here, we first summarize the main BK channel properties and its roles in pancreatic duct physiology. Then we focus on the potential role of BK as a pharmacological target in PDAC. Moreover, we discuss how results obtained when employing BK activators on cancer cells can, in some cases, be misleading. Frontiers Media S.A. 2022-05-24 /pmc/articles/PMC9171006/ /pubmed/35685628 http://dx.doi.org/10.3389/fphar.2022.906608 Text en Copyright © 2022 Zuccolini, Gavazzo and Pusch. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Zuccolini, Paolo
Gavazzo, Paola
Pusch, Michael
BK Channel in the Physiology and in the Cancer of Pancreatic Duct: Impact and Reliability of BK Openers
title BK Channel in the Physiology and in the Cancer of Pancreatic Duct: Impact and Reliability of BK Openers
title_full BK Channel in the Physiology and in the Cancer of Pancreatic Duct: Impact and Reliability of BK Openers
title_fullStr BK Channel in the Physiology and in the Cancer of Pancreatic Duct: Impact and Reliability of BK Openers
title_full_unstemmed BK Channel in the Physiology and in the Cancer of Pancreatic Duct: Impact and Reliability of BK Openers
title_short BK Channel in the Physiology and in the Cancer of Pancreatic Duct: Impact and Reliability of BK Openers
title_sort bk channel in the physiology and in the cancer of pancreatic duct: impact and reliability of bk openers
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171006/
https://www.ncbi.nlm.nih.gov/pubmed/35685628
http://dx.doi.org/10.3389/fphar.2022.906608
work_keys_str_mv AT zuccolinipaolo bkchannelinthephysiologyandinthecancerofpancreaticductimpactandreliabilityofbkopeners
AT gavazzopaola bkchannelinthephysiologyandinthecancerofpancreaticductimpactandreliabilityofbkopeners
AT puschmichael bkchannelinthephysiologyandinthecancerofpancreaticductimpactandreliabilityofbkopeners